Found: 5
Select item for more details and to access through your institution.
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
- Published in:
- European Journal of Endocrinology, 1998, v. 138, n. 3, p. 286, doi. 10.1530/eje.0.1380286
- By:
- Publication type:
- Article
Resistance to Cabergoline as Compared with Bromocriptine in Hyperprolactinemia: Prevalence, Clinical Definition, and Therapeutic Strategy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 11, p. 5256, doi. 10.1210/jcem.86.11.8054
- By:
- Publication type:
- Article
Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 6, p. 2247, doi. 10.1210/jcem.85.6.6657
- By:
- Publication type:
- Article
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 3, p. 807, doi. 10.1210/jcem.83.3.4674
- By:
- Publication type:
- Article
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
- Published in:
- Clinical Endocrinology, 2000, v. 53, n. 1, p. 53, doi. 10.1046/j.1365-2265.2000.01016.x
- By:
- Publication type:
- Article